![](https://www.microbiometimes.com/wp-content/uploads/2020/05/shutterstock_485314696-2-326x245.jpg)
A Checklist for Moving an LBP Through Manufacturing: The Biotech – CDMO Relationship
With increasing evidence for microbial involvement in many human diseases, live biotherapeutic products (LBPs)—living microbes administered therapeutically—have emerged as a group of exciting new drug candidates. Although the LBP regulatory environment remains uncertain, companies all […]